Discover 3,043 paid clinical trials in Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,043
New
Brain-Computer Interface Communication Device for People With ALS
for
Amyotrophic Lateral Sclerosis
Location: Santa Barbara CA
Sponsor: Cognixion
Sex: All
Age: 18+
Code: NCT07871071
Recruiting
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
for
Colitis, Ulcerative
Location: Los Alamitos CA, La Jolla CA, Mesa AZ, Littleton CO,
Sponsor: Pfizer
Sex: All
Age: 18 - 64
Code: NCT06398626
Recruiting
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Location: Duarte CA, Phoenix AZ, Scottsdale AZ, Salt Lake City UT,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT06131840
Phase 1, Recruiting
Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving Meditations
for
Chronic Disease, Infectious Disorder
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT04160429
Recruiting
Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial
for
Hematopoietic and Lymphoid System Neoplasm,
Location: Duarte CA, Lancaster CA, Upland CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 65+
Code: NCT06022965
Recruiting
A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
for
Advanced Cancer, Solid Tumor, Metastatic Cancer
Location: Duarte CA, Omaha NE, Miami FL
Sponsor: Proviva Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06190886
Phase 1, Recruiting
Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial
for
Locally Advanced Rectal Adenocarcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06834126
Phase 1, Recruiting
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Duarte CA, Kansas City KS, New York NY
Sponsor: GluBio Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06146257
Phase 1, Recruiting
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
for
B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma
Location: Duarte CA, Irvine CA, Columbus OH, Winston-Salem NC
Sponsor: City of Hope Medical Center
Sex: All
Age: 60+
Code: NCT06052826
Phase 2, Recruiting
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer
for
Platinum-Resistant Ovarian Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: Female
Age: 18+
Code: NCT05225363
Phase 1, Recruiting
A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
for
Recurrent Severe Aplastic Anemia,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 0 - 70+
Code: NCT05757310
Phase 1, Recruiting
Early Onset Colorectal Cancer Detection
for
Colorectal Cancer, Colorectal Neoplasms,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18 - 50
Code: NCT06342401
Recruiting
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial